This inventor holds 3 USPTO granted patents and 2 EPO patents. Top assignee: 7Tm Pharma A/s. Active years: 2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2012
Title: Innovations by Peter Aadal Nielsen
Introduction
Peter Aadal Nielsen is a notable inventor based in Hoersholm, Denmark. He has made significant contributions to the field of cannabinoid receptor modulators, with a focus on compounds that can aid in the treatment of obesity. With a total of 3 patents to his name, Nielsen's work is paving the way for advancements in therapeutic applications.
Latest Patents
Nielsen's latest patents include innovative cannabinoid receptor modulators. These compounds are designed to modulate the cannabinoid receptor CB1, which is useful for treating obesity. The compounds of formula (I) suppress the normal signaling activity of CB1 receptors, making them valuable in addressing diseases and conditions associated with obesity and overweight.
Career Highlights
Throughout his career, Peter Aadal Nielsen has been associated with 7tm Pharma A/S, where he has been instrumental in developing new therapeutic solutions. His research focuses on the intricate mechanisms of cannabinoid receptors and their potential applications in medicine.
Collaborations
Nielsen has collaborated with esteemed colleagues such as Jean-Marie Receveur and Thomas Hoegberg. These partnerships have enhanced the research and development efforts at 7tm Pharma A/S, contributing to the advancement of cannabinoid-based therapies.
Conclusion
Peter Aadal Nielsen's innovative work in cannabinoid receptor modulation highlights his commitment to addressing obesity-related health issues. His contributions are significant in the ongoing quest for effective treatments in this area.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile